Seattle-based Bardy Diagnostics, Inc., a provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (CAM), a P-wave centric ambulatory cardiac monitor and arrhythmia detection device, announces that it was selected as one of six winners of the “Make Your Medical Device Pitch for Kids!” Competition hosted by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.
Eleven finalists from a field of 45 worldwide submissions were selected to present their products this past weekend at the Sixth Annual Pediatric Device Innovation Symposium. A distinguished judging panel of industry experts awarded BardyDx a $25,000 prize based on the CAM patch’s design, P-wave-centric technology, and potential to address significant unmet needs in pediatric healthcare.
“BardyDx is excited to receive this award and this honor reinforces our commitment to the advancement of pediatric cardiology care,” says Ken Nelson, BardyDx chief commercial officer. “The CAM patch is one of only a few FDA-approved products that is commercially available for patients weighing 10 kg (22 lbs) or more. This award prize will be used toward development efforts to expand our labeling to cover all of pediatrics and make the CAM patch the gold-standard for pediatric ambulatory cardiac monitoring.”
The competition is one of the highlights of this year’s symposium, themed “Using Real-World Evidence to Drive Pediatric Innovation,” organized by Children’s National to bring together medical device innovators, investors, researchers, clinicians, and policy makers to advance pediatric healthcare and address the unmet surgical and medical device needs of children. Along with the theme, BardyDx’s body of clinical evidence recently expanded, highlighting the significance of the CAM patch’s P-wave focused clinical value in this month’s issue of the American Heart Journal.
“We are honored to recognize these outstanding innovations and we already envision the ways they can advance care for children,” says Kolaleh Eskandanian, PhD, vice president and chief innovation officer at Children’s National and Principal Investigator of the National Capital Consortium for Pediatric Device Innovation.
